Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Department of Pharmacology, University of Oxford, Oxford, UK.
J Neurochem. 2019 Mar;148(5):625-638. doi: 10.1111/jnc.14483. Epub 2018 Aug 9.
Approximately 70 lysosomal storage diseases are currently known, resulting from mutations in genes encoding lysosomal enzymes and membrane proteins. Defects in lysosomal enzymes that hydrolyze sphingolipids have been relatively well studied. Gaucher disease is caused by the loss of activity of glucocerebrosidase, leading to accumulation of glucosylceramide. Gaucher disease exhibits a number of subtypes, with types 2 and 3 showing significant neuropathology. Sandhoff disease results from the defective activity of β-hexosaminidase, leading to accumulation of ganglioside GM2. Niemann-Pick type C disease is primarily caused by the loss of activity of the lysosomal membrane protein, NPC1, leading to storage of cholesterol and sphingosine. All three disorders display significant neuropathology, accompanied by neuroinflammation. It is commonly assumed that neuroinflammation is the result of infiltration of monocyte-derived macrophages into the brain; for instance, cells resembling lipid-engorged macrophages ('Gaucher cells') have been observed in the brain of Gaucher disease patients. We now review the evidence that inflammatory macrophages are recruited into the brain in these diseases and then go on to provide some experimental data that, at least in the three mouse models tested, monocyte-derived macrophages do not appear to infiltrate the brain. Resident microglia, which are phenotypically distinct from infiltrating macrophages, are the only myeloid population present in significant numbers within the brain parenchyma in these authentic mouse models, even during the late symptomatic stages of disease when there is substantial neuroinflammation. OPEN SCIENCE BADGES: This article has received a badge for Open Materials because it provided all relevant information to reproduce the study in the manuscript. The complete Open Science Disclosure form for this article can be found at the end of the article. More information about the Open Practices badges can be found at https://cos.io/our-services/open-science-badges/. This article is part of the Special Issue "Lysosomal Storage Disorders".
目前已知约有 70 种溶酶体贮积症,这些疾病是由于编码溶酶体酶和膜蛋白的基因突变引起的。溶酶体酶水解鞘脂的缺陷已得到相对较好的研究。戈谢病是由于葡萄糖脑苷脂酶活性丧失,导致葡萄糖脑苷脂堆积引起的。戈谢病表现出多种亚型,其中 2 型和 3 型表现出明显的神经病理学。桑德霍夫病是由于β-己糖胺酶活性缺陷,导致神经节苷脂 GM2 堆积引起的。尼曼-匹克 C 型病主要是由于溶酶体膜蛋白 NPC1 的活性丧失,导致胆固醇和神经酰胺的储存。所有这三种疾病都表现出明显的神经病理学,伴有神经炎症。人们通常认为神经炎症是单核细胞衍生的巨噬细胞浸润到大脑的结果;例如,在戈谢病患者的大脑中观察到类似于富含脂质的巨噬细胞('戈谢细胞')的细胞。我们现在回顾了这些疾病中炎症性巨噬细胞被招募到大脑中的证据,然后提供了一些实验数据,至少在我们测试的三种小鼠模型中,单核细胞衍生的巨噬细胞似乎没有浸润大脑。在这些真实的小鼠模型中,只有表型上不同于浸润性巨噬细胞的常驻小胶质细胞,以大量存在于脑实质中,即使在疾病的晚期症状阶段,存在大量神经炎症时也是如此。开放科学徽章:本文获得了“开放材料”徽章,因为它提供了复制本文中研究所需的所有相关信息。本文的完整开放科学披露表格可以在文章末尾找到。有关开放实践徽章的更多信息可以在 https://cos.io/our-services/open-science-badges/ 找到。本文是“溶酶体贮积症特刊”的一部分。